Introducing Eversense 365.
The only CGM that lasts a year.
Wave a long goodbye to traditional, short-term CGMs. Eversense 365 gives you one year of real-time continuous glucose readings with minimal device frustrations.
4 reasons to get Eversense 365
Longest lasting CGM
Eversense 365 is the only CGM that lasts for a year, while traditional 10-14 day CGM sensors tend to fail early.1-3
No more wasted CGMs
Our tiny sensors are designed to rest comfortably under your skin. Plus, our removable smart transmitter can be taken off* and put back on without wasting a CGM.
Alerts you can trust
Eversense CGMs have exceptional accuracy, with almost no false alerts from compression lows while you’re sleeping.4
Maximum comfort
Our gentle, silicone-based adhesives are changed daily and cause almost no skin reactions.5
The Eversense 365 System
The difference is inside. See how Eversense 365 gives you real-time, reliable glucose readings from a tiny sensor under the skin in your upper arm.
Eversense 365 is covered by most commercial health plans6
Covered by most commercial health plans6
If you have commerical insurance you may be eligible to pay as little as $199 for a full year7
Available to people with Medicare8
Getting Started Is Simple
A short, in-office procedure is all it takes for more peace of mind over your diabetes management. Get started in a few simple steps. Begin by taking a short quiz to see if you qualify.
The Most Frequently Asked Questions
Eversense 365 gives you real-time glucose readings through a small sensor that’s placed just under the skin of your upper arm by a healthcare professional. The smart transmitter sits above the sensor, sending glucose data to your app. Want to learn more about the science behind Eversense 365? Check out our “How Eversense Works” video!
Eversense 365 offers the only implantable sensors for long term wear - see how we compare!
If you’re on insulin and if you answer yes to any of the below questions, you may be a great candidate for Eversense 365!
1. Would you prefer only 1 sensor change a year?
2. Do you have skin irritation from the adhesive of your current CGM?
3. Are you tired of false lows/false readings or gaps in data?
4. Would you like to have the freedom to remove your CGM transmitter without wasting the sensor?
5. Do your CGM alerts sometimes disrupt those around you?
Download our discussion guide and bring it to your next appointment and talk to your doctor about how Eversense 365 may be a better fit for your diabetes management plan. We will work with you and your health care provider to manage your insurance claim.
Depending on your specific insurance plan, there could be differences in cost. We are happy to help you navigate getting more information about your insurance coverage. Just fill out the Pre-Qualification form, and we will be happy to contact you.
Pre-Qualify for Eversense 365
If you're on insulin, you might greatly benefit from Eversense 365. Whether you’re ready to get started now or just have additional questions about Eversense 365, an Ascensia Diabetes Care (Ascensia) representative can help.
You may pre-qualify for Eversense 365 based on your insurance type and diabetes therapy. Fill in and submit the form below and we’ll be in touch via phone or text. We’ll also send you information about Eversense 365 by email.
All fields marked with an asterisk (*) are required.
Thanks! We've got your info.
A Diabetes Therapy Associate will be in touch shortly, but if you want to reach out sooner, please call 1-945-221-9068.
To help expedite benefits verification, please have your doctor and insurance information handy.
We will attempt to reach you by phone first, and will send a text and email as well. The call may be displayed on your phone as "Eversense CGM". However, it will come from a number you are unfamiliar with, so be sure to check your voicemail box. The email from our representative will come from an @ascensia.com email address. If you haven’t received any email communications from our team within a few days, please check the spam folder in your email account.
You can also schedule your call with us at a date/time that is most convenient for you - just click here.
Looking forward to getting in touch with you!
Thanks! We've got your info.
Unfortunately, based on the insulin therapy regimen or insurance information you provided, you may not be eligible for Eversense E3 CGM. In order to qualify, you must be on multiple daily doses of insulin.
If your commercial insurance plan does not cover Eversense E3 CGM, our Eversense PASS™ program may help reduce your out-of-pocket cost for the product. .
If you have any questions, please reach out to 1-844-736-7348.
* There is no glucose data generated when the transmitter is removed
1. Abbott. (2024) Freestyle Libre 3 User Guide ART49385-001 Rev. A 04/24
2. Dexcom (2024) G7 User Guide AW00078-10 Rev 003 MT-00078-10
3. Senseonics. (2024) Eversense 365 Continuous Glucose Monitoring System User Guide. LBL-7702-01-001 Rev A
4. Christiansen MP et al. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. DIABETES TECHNOLOGY & THERAPEUTICS 2018; 20(3):197-206
5. Deiss, D. et al. (2020). Real-world safety of an implantable continuous glucose sensor over multiple cycles of use: A post-market registry study. Diabetes Technology and Therapeutics, 22(1), 48–52. https://doi.org/10.1089/dia.2019.0159
6. Data on File. Senseonics. Policy Reporter (8/23/2024)
7. Offer does not apply to the insertion and removal procedures. The Eversense PASS Program has limitations on eligibility. See website (bit.ly/EversensePass) for more details. Ascensia Diabetes Care reserves the right to change or terminate this program at any time without notice. The program benefit is capped per transaction. There may be instances in which patient out-of-pocket costs exceed what is detailed in the offer. Eversense E3 is not eligible for the PASS Program.
8. Speak to an Eversense Expert for more information on Medicare coverage.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
PP-SENS-E3-GBL-0059